Related Experiment Video
Updated: Dec 24, 2025

Novel Diagnostics in Revision Arthroplasty: Implant Sonication and Multiplex Polymerase Chain Reaction
Published on: December 3, 2017
[PCR research as an auxiliary method for diagnostics of periphresitical infection after endostreditision of joints
N Y Dobrovol'skaya1, N P Prishchepa1, E V Preobrazhenskaya1
1Federal State Budgetary Institution Federal Center of Traumatology, Orthopedics and endoprosthesis replacement of Ministry of Health of the Russian Federation, 428020, Cheboksary, Chuvash Republic, Russia.
Abstract:
Periprosthetic infection (PPI) after arthroplasty of large joints is the third (among the main causes of unsatisfactory results of surgical treatment) a serious threat to the health of patients. The «gold standard» for the diagnosis of PPI is the bacteriological examination of samples of periprosthetic tissues and synovial fluid. In 10-30% of cases, it is impossible to isolate microorganisms, which is explained by the difficulty of cultivation and taking antibiotics before sampling. The purpose of study is to demonstrate the diagnostic value of PCR diagnostics for identifying the genetic material of an infectious pathogen of a culture-negative periprosthetic infection. Material of the study is a description of a clinical case of a culture-negative periprosthetic infection that caused a second two-stage revision of the hip joint prosthesis In the first episode of PPI that occurred 3 years after hip replacement, a microbiological examination of the puncture of the trochanteric zone of the operated joint revealed a massive increase in methicillin-resistant Staphylococcus epidermidis (MRSE). A two-stage revision joint replacement was performed. 5 years after the revision, the patient was hospitalized with clinical and radiological signs of PPI, while examining the puncture of the joint revealed characteristic PPI cytosis. Microbiological examination of punctate and intraoperative aspirate at the first stage of the repeated two-stage revision endoprosthesis replacement did not reveal aerobic and anaerobic microorganisms. In PCR studies, the DNA of methicillin-sensitive Staphylococcus aureus (MSSA) was detected in washouts from the removed components of the endoprosthesis; no resistance marker (mecA gene) was found. Given the concomitant oncological disease, this result determined the appointment of pathogenetic antibiotic therapy, the effectiveness of which was confirmed after 8 weeks at the II stage of revision. The PCR study of joint and trochanteric punctures (before surgery), flushing from the removed spacer components (after ultrasound treatment) and intraoperative aspirate from the joint did not reveal Staphylococcus aureus DNA and resistance marker (mecA gene). In some cases of periprosthetic infection, traumatologists and orthopedists deal with culturally negative results of a microbiological study of the patient's biomaterial and swabs from the components of endoprostheses in the presence of clinical manifestations of PPI, confirmed by laboratory diagnostics and X-ray examination. According to the literature, such clinical situations are observed in 10-30% of cases and are caused by previous antibiotic therapy in the early stages of an infectious complication. After surgical treatment of PPI for the selection of adequate antibiotic therapy, such patients need to at least indirectly determine the type of infection pathogen, which is achieved by the use of additional diagnostic methods, such as a PRC study. In the case described by us, after a course of antibiotic therapy, prescribed according to the results of the first PCR study, the patient's body does not contain DNA traces of the desired infectious agent. Thus, the repeated PCR not only confirmed the accuracy of the initial diagnosis of the source of infection, but also further illustrated the success of the rehabilitation of the periprosthetic infection using a correctly selected antibacterial drug at the previous stage of the study. The use of the PCR method made it possible to diagnose the pathogen and prescribe adequate antibiotic therapy for culture-negative periprosthetic infection.
Insights
Polymerase chain reaction (PCR) diagnostics can identify pathogens in culture-negative periprosthetic joint infections. This method aids in selecting effective antibiotic therapy for challenging cases, improving patient outcomes.
Area of Science:
- Orthopedic Surgery
- Infectious Diseases
- Molecular Diagnostics
Background:
- Periprosthetic joint infection (PPI) is a significant complication of arthroplasty, leading to poor outcomes.
- Standard microbiological diagnostics fail in 10-30% of PPI cases due to difficulties in pathogen cultivation.
- Culture-negative PPI presents a diagnostic challenge for selecting appropriate antibiotic therapy.
Purpose of the Study:
- To demonstrate the diagnostic value of PCR for identifying pathogens in culture-negative PPI.
- To highlight the utility of PCR in guiding antibiotic selection for revision arthroplasty.
Main Methods:
- Case report of a patient with recurrent culture-negative PPI after hip arthroplasty.
- Utilized PCR to detect microbial DNA in periprosthetic samples.
- Correlated PCR findings with clinical presentation and treatment response.
Main Results:
- PCR identified methicillin-sensitive Staphylococcus aureus (MSSA) DNA in periprosthetic samples, despite negative cultures.
- Antibiotic therapy guided by PCR results was effective in treating the infection.
- Repeated PCR confirmed the absence of target DNA after successful treatment.
Conclusions:
- PCR is a valuable tool for diagnosing culture-negative PPI.
- PCR enables targeted antibiotic therapy, improving outcomes in complex cases.
- This approach aids in overcoming limitations of traditional microbiological methods.
Related Concept Videos
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Acute Pyelonephritis II: Diagnostic Studies and Management
Endocarditis I: Introduction
Endocarditis II: Clinical Features of Infective Endocarditis
Pneumonia III: Complications and Assessment
Endocarditis III: Medical Management

